Please provide your email address to receive an email when new articles are posted on . In the PACUBA trial, a paclitaxel-eluting balloon was associated with significantly higher primary patency at 1 ...

Please provide your email address to receive an email when new articles are posted on . One-year data from the EXCITE ISR trial demonstrate that use of excimer laser atherectomy plus percutaneous ...

Health-Economic Analysis Demonstrates Medtronic IN.PACT Admiral Drug-Coated Balloon Is Cost-Effective Compared to Standard PTA; Global Study Data Demonstrates Strong Clinical Outcomes in Patients with ...

BUELACH, SWITZERLAND--(Marketwire - Sep 14, 2012) - Following the success of BIOTRONIK's Pulsar-18 0.018"/4F-platform self-expanding stent system, the company has now introduced its Pulsar stent ...

Introduction: The effect of stent-assisted percutaneous transluminal angioplasty (PTA) for renal artery stenosis (RAS) on systolic (SBP) and diastolic blood pressure (DBP) as well as renal function, ...

It's not unusual to hear about people who receive heart stents. For many years, physicians have used angioplasty and stenting to open blocked coronary arteries. The procedure involves inserting a very ...

November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...

Introduction: There are no systematic tools to predict blood pressure (BP) or renal function (RF) improvement after stent-assisted percutaneous transluminal angioplasty (PTA) for atherosclerotic renal ...

Laser atherectomy uses light to break down hyperplastic tissue in an atherosclerotic plaque or restenosis of a stented lesion. In a new paper published in JACC Cardiovascular Interventions, ...